Jodhpur AIIMS purchased additional material worth Rs 2.32 crore during Covid

Jodhpur : Jodhpur During the Corona epidemic, where people were yearning for one Remdesivir injection, a large quantity of Remdesivir injections were purchased in AIIMS Jodhpur. Of these, 2449 injections worth Rs 57,36,800 expired due to not being used. The investigation found that AIIMS had made irregular purchases in excess of the requirement. There were 3567 injections available at AIIMS at the beginning of May 2021. Despite this, 1080, 1520 and 1341 injections were purchased from different companies on May 18, May 21 and May 25 respectively. After checking the stock, 5 thousand 949 Remdesivir injections were left. Out of this, maximum 3500 free of cost injections turned out to be unexpired. The remaining injections 2449 expired due to expiry.

In CAG investigation, medicines worth more than Rs 87 lakh had expired. Apart from this, in other checks of the stock register, other consumables were purchased during October 2018 to June 2020. Investigation revealed that goods worth Rs 2.32 crore were remaining. In its reply to CAG, AIIMS said that due to the Corona epidemic, all types of operation theaters were not in operation except in emergency situations, hence this material could not be used. CAG did not seem satisfied here either. CAG says that the Corona epidemic spread in March 2020, while some material was purchased one and a half years before that, some material was also purchased in April 2020 and June 2020, at that time the Corona epidemic was at its peak. It is clear from this that funds were blocked by purchasing material without actual assessment and requirement.

AIIMS had enough injections, yet bought more

When CAG sought a reply in this regard, AIIMS argued that these injections could not be used due to the huge decline in patients of the Covid pandemic during the year 2021-22. CAG AIIMS seemed dissatisfied with this. The CAG said the injections were procured despite there being sufficient quantity. Their expiry dates were April 2022 and October 2022. Due to improper use of medicines, there was a loss of Rs 57,36,800 lakh.

Leave a Comment

Read Next